Evidence map›Paper›PMID 42797711›Full record

ReviewToxics2026

Emerging PFAS: Current Concerns, Remediation, and Future Perspectives.

Ryuichi Mashima

Abstract readReview
In one paragraph

Review in Toxics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ryuichi MashimaDepartment of Clinical Laboratory Medicine, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan.

Funding

Japan Society for the Promotion of Science Number 25K11117
6 · The paper itself

Abstract

Emerging per- and polyfluoroalkyl substances (PFAS) constitute the most currently available PFAS used across many applications, such as aqueous film-forming foam, textiles, food contact materials, chromium plating, semiconductor production, and fluoropolymer producing aids. Since the Stockholm convention, legacy PFAS has been successfully replaced to emerging PFAS. In addition, emerging PFAS can be generated from industrial mitigation process of legacy PFAS, inadvertently from previously emitted fluorocarbons by photooxidation, and is generated for new application such as lithium battery electrolyte. This review first defines emerging PFAS in this manuscript followed by overviewing of their production and mitigation process based on recent advances in technology.

Indexed as

biological transformationemerging PFASregulationremediationultrashort-chain PFAS

Identifiers

PMID42797711
PMCPMC13611077

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.